Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0000899243-22-001169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-01-06 | 2022-01-04+ | BBIO | Dachille Douglas A. | Dir | P - Purchase | $16.36 | +10.0K | 10.0K | New | +$163.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-04 | P | A | 5,000 | $16.82 | 5,000 | I By The Dachille 2012-1 Family Trust | — | — | (F1) These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |
| 2 | Common | Common Stock | 2022-01-05 | P | A | 5,000 | $15.91 | 10,000 | I By The Dachille 2012-1 Family Trust | — | — | (F1) These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. |